Cargando…

What data collection methods work best for COVID19 outbreak surveillance for people with end stage kidney disease? An observational cohort study using the UK Renal Registry

BACKGROUND: Patients on kidney replacement therapy (KRT) are vulnerable to severe illness from COVID-19. Timely, accurate surveillance is essential for planning and implementing infection control at local, regional and national levels. Our aim was to compare two methods of data collection for COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales: Santhakumaran, Shalini, Savino, Manuela, Benoy-Deeney, Fran, Steenkamp, Retha, Medcalf, James, Nitsch, Dorothea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166021/
https://www.ncbi.nlm.nih.gov/pubmed/37158816
http://dx.doi.org/10.1186/s12882-023-03148-8
_version_ 1785038359619436544
author Santhakumaran, Shalini
Savino, Manuela
Benoy-Deeney, Fran
Steenkamp, Retha
Medcalf, James
Nitsch, Dorothea
author_facet Santhakumaran, Shalini
Savino, Manuela
Benoy-Deeney, Fran
Steenkamp, Retha
Medcalf, James
Nitsch, Dorothea
author_sort Santhakumaran, Shalini
collection PubMed
description BACKGROUND: Patients on kidney replacement therapy (KRT) are vulnerable to severe illness from COVID-19. Timely, accurate surveillance is essential for planning and implementing infection control at local, regional and national levels. Our aim was to compare two methods of data collection for COVID-19 infections amongst KRT patients in England. METHODS: Adults receiving KRT in England were linked to two sources of data on positive COVID-19 tests recorded March-August 2020: (1) submissions from renal centres to the UK Renal Registry (UKRR) and (2) Public Health England (PHE) laboratory data. Patient characteristics, cumulative incidence by modality (in-centre haemodialysis (ICHD), home HD, peritoneal dialysis (PD) and transplant), and 28-day survival were compared between the two sources. RESULTS: 2,783/54,795 patients (5.1%) had a positive test in the combined UKRR-PHE dataset. Of these 2,783, 87% had positive tests in both datasets. Capture was consistently high for PHE (> 95% across modalities) but varied for UKRR (ranging from ICHD 95% to transplant 78%, p < 0.0001). Patients captured only by PHE were more likely to be on transplant or home therapies (OR 3.5 95% CI [2.3–5.2] vs. ICHD) and to be infected in later months (OR 3.3 95%CI [2.4–4.6] for May-June, OR 6.5 95%CI [3.8–11.3] for July-August, vs. March-April), compared to patients in both datasets. Stratified by modality, patient characteristics and 28-day survival were similar between datasets. CONCLUSIONS: For patients undergoing ICHD treatment the collection of data submitted directly by renal centres allows constant monitoring in real time. For other KRT modalities, using a national swab test dataset through frequent linkage may be the most effective method. Optimising central surveillance can improve patient care by informing interventions and assisting planning at local, regional and national levels. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03148-8.
format Online
Article
Text
id pubmed-10166021
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101660212023-05-09 What data collection methods work best for COVID19 outbreak surveillance for people with end stage kidney disease? An observational cohort study using the UK Renal Registry Santhakumaran, Shalini Savino, Manuela Benoy-Deeney, Fran Steenkamp, Retha Medcalf, James Nitsch, Dorothea BMC Nephrol Research BACKGROUND: Patients on kidney replacement therapy (KRT) are vulnerable to severe illness from COVID-19. Timely, accurate surveillance is essential for planning and implementing infection control at local, regional and national levels. Our aim was to compare two methods of data collection for COVID-19 infections amongst KRT patients in England. METHODS: Adults receiving KRT in England were linked to two sources of data on positive COVID-19 tests recorded March-August 2020: (1) submissions from renal centres to the UK Renal Registry (UKRR) and (2) Public Health England (PHE) laboratory data. Patient characteristics, cumulative incidence by modality (in-centre haemodialysis (ICHD), home HD, peritoneal dialysis (PD) and transplant), and 28-day survival were compared between the two sources. RESULTS: 2,783/54,795 patients (5.1%) had a positive test in the combined UKRR-PHE dataset. Of these 2,783, 87% had positive tests in both datasets. Capture was consistently high for PHE (> 95% across modalities) but varied for UKRR (ranging from ICHD 95% to transplant 78%, p < 0.0001). Patients captured only by PHE were more likely to be on transplant or home therapies (OR 3.5 95% CI [2.3–5.2] vs. ICHD) and to be infected in later months (OR 3.3 95%CI [2.4–4.6] for May-June, OR 6.5 95%CI [3.8–11.3] for July-August, vs. March-April), compared to patients in both datasets. Stratified by modality, patient characteristics and 28-day survival were similar between datasets. CONCLUSIONS: For patients undergoing ICHD treatment the collection of data submitted directly by renal centres allows constant monitoring in real time. For other KRT modalities, using a national swab test dataset through frequent linkage may be the most effective method. Optimising central surveillance can improve patient care by informing interventions and assisting planning at local, regional and national levels. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03148-8. BioMed Central 2023-05-08 /pmc/articles/PMC10166021/ /pubmed/37158816 http://dx.doi.org/10.1186/s12882-023-03148-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Santhakumaran, Shalini
Savino, Manuela
Benoy-Deeney, Fran
Steenkamp, Retha
Medcalf, James
Nitsch, Dorothea
What data collection methods work best for COVID19 outbreak surveillance for people with end stage kidney disease? An observational cohort study using the UK Renal Registry
title What data collection methods work best for COVID19 outbreak surveillance for people with end stage kidney disease? An observational cohort study using the UK Renal Registry
title_full What data collection methods work best for COVID19 outbreak surveillance for people with end stage kidney disease? An observational cohort study using the UK Renal Registry
title_fullStr What data collection methods work best for COVID19 outbreak surveillance for people with end stage kidney disease? An observational cohort study using the UK Renal Registry
title_full_unstemmed What data collection methods work best for COVID19 outbreak surveillance for people with end stage kidney disease? An observational cohort study using the UK Renal Registry
title_short What data collection methods work best for COVID19 outbreak surveillance for people with end stage kidney disease? An observational cohort study using the UK Renal Registry
title_sort what data collection methods work best for covid19 outbreak surveillance for people with end stage kidney disease? an observational cohort study using the uk renal registry
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166021/
https://www.ncbi.nlm.nih.gov/pubmed/37158816
http://dx.doi.org/10.1186/s12882-023-03148-8
work_keys_str_mv AT santhakumaranshalini whatdatacollectionmethodsworkbestforcovid19outbreaksurveillanceforpeoplewithendstagekidneydiseaseanobservationalcohortstudyusingtheukrenalregistry
AT savinomanuela whatdatacollectionmethodsworkbestforcovid19outbreaksurveillanceforpeoplewithendstagekidneydiseaseanobservationalcohortstudyusingtheukrenalregistry
AT benoydeeneyfran whatdatacollectionmethodsworkbestforcovid19outbreaksurveillanceforpeoplewithendstagekidneydiseaseanobservationalcohortstudyusingtheukrenalregistry
AT steenkampretha whatdatacollectionmethodsworkbestforcovid19outbreaksurveillanceforpeoplewithendstagekidneydiseaseanobservationalcohortstudyusingtheukrenalregistry
AT medcalfjames whatdatacollectionmethodsworkbestforcovid19outbreaksurveillanceforpeoplewithendstagekidneydiseaseanobservationalcohortstudyusingtheukrenalregistry
AT nitschdorothea whatdatacollectionmethodsworkbestforcovid19outbreaksurveillanceforpeoplewithendstagekidneydiseaseanobservationalcohortstudyusingtheukrenalregistry